Catalent
CTLT
#1496
Rank
$11.52 B
Marketcap
$63.48
Share price
0.00%
Change (1 day)
44.60%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $6.16 Billion USD

According to Catalent's latest financial reports the company's total liabilities are $6.16 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30$6.16 B7.55%
2022-06-30$5.73 B18.5%
2021-06-30$4.83 B13.28%
2020-06-30$4.27 B9.63%
2019-06-30$3.89 B13.11%
2018-06-30$3.44 B26.13%
2017-06-30$2.73 B11.23%
2016-06-30$2.45 B-1.96%
2015-06-30$2.50 B-27.66%
2014-06-30$3.46 B3.04%
2013-06-30$3.35 B-3.72%
2012-06-30$3.48 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$0.33 B-94.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.53 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.08 B 31.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.32 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA